Investors

Press releases

August 30, 2023 Regulatory

LIDDS AB (publ) Interim Report January – June 2023

July 31, 2023 Regulatory

LIDDS appoints Matthew Lindon as acting CEO

July 7, 2023 Non Regulatory

Interview with LIDDS’s Chairman of the Board published on the company’s website

July 6, 2023 Regulatory

LIDDS announces closure of R&D project with Johnson & Johnson Enterprise Innovation Inc.

All press releases

Financial calendar

November 17, 2023

Interim Report January – September 2023
Add to calendar
February 22, 2024

Year-end report 2023
Add to calendar

All events

Interim Report Q2 2023

LIDDS published the Interim report for Q2 2023 on August 30, 2023.

Report

Read more

The share

The share

Cancer – a growing public health problem

19 Million

new cancer cases in 2020
187 Bn USD

in sales of cancer drugs in 2021
9.9 Bn USD

in sales of prostate cancer drugs in 2026